Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Sacituzumab Govitecan for Thymic Cancer
Recruiting1 awardPhase 2
Palo Alto, California
This trial aims to see how sacituzumab govitecan-hziy affects adult patients with advanced thymoma and thymic carcinoma who have not responded to previous treatments. Patients will
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service